MedPath

Pilot-Study DCPT for PTSD in Adolescents and Young Adults

Not Applicable
Completed
Conditions
PTSD
Registration Number
NCT01870271
Lead Sponsor
Goethe University
Brief Summary

The aim of this pilot study is to evaluate the developmentally adapted cognitive processing therapy (D-CPT)in adolescents suffering from childhood abuse(CA)or physical abuse (PA) related PTSD. D-CPT's feasibility and efficacy will be examined in 20 adolescents suffering from CA or PA-related PTSD in a multicenter study (3 sites).Patients will be assessed prior to (t0), post (t1) and 6 weeks after treatment (t2). Assessments include Clinician Administered PTSD Scale (CAPS), UCLA PTSD Index (UCLA), Beck Depression Inventory (BDI), Adolescent Dissociative Experiences Scale (A-DES), and Borderline Symptom List (BSL-23).

Detailed Description

The aim of this pilot study is to evaluate the developmentally adapted cognitive processing therapy (D-CPT)in adolescents suffering from childhood sexual abuse (CA) or childhood physical abuse (PA) related PTSD. D-CPT's feasibility and efficacy will be examined in 20 adolescents suffering from CA or PA-related PTSD in a multicenter study in Berlin, Frankfurt and Ingolstadt in Germany (3 sites).Patients will be assessed prior to (t0), post (t1) and 6 weeks after treatment (t2). Assessments include Clinician Administered PTSD Scale (CAPS), UCLA PTSD Index (UCLA), Beck Depression Inventory (BDI), Adolescent Dissociative Experiences Scale (A-DES), and Borderline Symptom List (BSL-23).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • PTSD after CSA and/or CPA beyond the age of three (confirmed by a structured clinical interview, CAPS-CA, German Version IBS-KJ)
  • PTSD must be the primary diagnosis (most severe disorder according to SCID)
  • age 14 - 21 years
  • living in safe conditions
  • informed consent from parents/legal guardians (if under 18) and participant
Exclusion Criteria
  • current psychotic
  • substance related or organic mental disorder
  • acute suicidality, severe medical conditions
  • mental retardation
  • insufficient knowledge of German language.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Clinician-Administered PTSD-Scale for Children and Adolescentst0=pretreatment (baseline), t1= change from baseline at post-treatment after 20 weeks t2= change from posttreatment at 6 weeks follow-up
Secondary Outcome Measures
NameTimeMethod
UCLA PTSD Index (UCLA)t0=pretreatment (baseline), t1= change from baseline at post-treatment after 20 weeks t2= change from posttreatment at 6 weeks follow-up
Beck Depression Inventoryt0=pretreatment (baseline), t1= change from baseline at post-treatment after 20 weeks t2= change from posttreatment at 6 weeks follow-up

Trial Locations

Locations (1)

Department of Clinical Psychology and Psychotherapy, Goethe University

🇩🇪

Frankfurt, Hessen, Germany

Department of Clinical Psychology and Psychotherapy, Goethe University
🇩🇪Frankfurt, Hessen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.